| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2988913 | Journal of Vascular Surgery | 2014 | 9 Pages |
Abstract
EVAR is currently associated with significant negative operating margins among Medicare beneficiaries. Currently, device costs account for over 50% of EVAR-associated technical costs and did not impact EVAR market share, reflecting an unawareness of cost differential among surgeons. These data indicate that EVAR must undergo dramatic care delivery redesign for this practice to remain sustainable.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
David H. MD, Alexander J. BA, Philip P. MD, Eva M. MD, Brian W. MD, Daniel B. MD, Robert M. MD, PhD, Richard J. MD,